The U.S. Food and Drug Administration today approved Jakafi (ruxolitinib), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis
The whole story is right here: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm280102.htm
and here: http://incyte.com/ If you want a refresher on the drug, there’s a story at https://mpnforum.com/2011/10/12/ruxolitini/ or go to www.mpnforum.com, head for the SEARCH box on the right and type in Ask the Doctors. This is an interview with primary investigators Dr. Srdan Verstovsek and Dr. Ruben Mesa.
Now…let’s see what our hematologists and insurance providers make of the news.